newsfilter
← Latest News
PR Newswire·

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today announced the appointment of Darren Snellgrove as Chief Financial...